Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DIALOSA TABLET 3MG - HSA Drug Approval Details

Approvals/HSA/DIALOSA TABLET 3MG

Approved

THERAPEUTIC

DIALOSA TABLET 3MG

PharmaPath SA🇸🇬 Health Sciences Authority

Approval Date: Jul 20, 2009
Approval ID: 5581826558e4bf6e
Company: PharmaPath SA
Type: Therapeutic

Approval Details

Approval Id: 5581826558e4bf6e
Drug Name: DIALOSA TABLET 3MG
Product Name: DIALOSA TABLET 3MG
Approval Number: SIN13674P
Approval Date: 2009-07-20
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Licence Holder: GOLDPLUS UNIVERSAL PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: A10BB12
Atc Item Name: glimepiride
Pharma Manufacturer Name: GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path: /organization/goldplus-universal-pte-ltd

Active Ingredients

GLIMEPIRIDE

3MG

GLIMEPIRIDE

3 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jul 20, 2009

Approval ID

5581826558e4bf6e

Type

Therapeutic

Back to HSA Approvals